Jeff Yass’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Jeff Yass’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,328	Closed	-$660	–	14153
2022 Q4	$660	Buy	+10,328	New	+$395	﹤0.01%	12197
2022 Q2	–	Sell	-15,354	Closed	-$4K	–	14410
2022 Q1	$4K	Sell	15,354 -10,331	-40%	-$3.29K	﹤0.01%	12839
2021 Q4	$17K	Sell	25,685 -4,544	-15%	-$3.15K	﹤0.01%	12860
2021 Q3	$20K	Hold	30,229	–	–	﹤0.01%	12551
2021 Q2	$26K	Buy	+30,229	New	+$21K	﹤0.01%	12405

Jeff Yass's BIOTW Position: Q1 2023 in Review

Jeff Yass sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 10,328 shares — an estimated $660 sold.

Jeff Yass first reported a position in BIOTW in Q2 2021 and held it in 5 quarters. The position peaked at $26K in Q2 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

Jeff Yass reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
Jeff Yass sold 10,328 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $660.
Jeff Yass first reported a position in Biotech Acquisition Company Warrant in Q2 2021 and held it in 5 quarters.
Jeff Yass's Biotech Acquisition Company Warrant position peaked at $26K in Q2 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.